| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| KIR3DS1 |
Q14943
|
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.617 |
0.692 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| DEFB103B |
P81534
|
defensin beta 103B
|
|
|
0.572 |
0.731 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |